Amongst the other suggestions with the WHO, there was the proposed addition of the footnote on the Routine I area of the Convention, stating that preparations containing predominantly cannabidiol instead of more than 0.2 per cent of delta-nine-tetrahydrocannabinol usually are not under Worldwide Handle.[35] Even so, the proposal was ultimately turn